Nadav Friedmann

Nadav Friedmann

No más puestos en curso
83 años
Health Technology
Consumer Services
Finance

Perfil

Nadav Friedmann served as President & Chief Executive Officer at DaIIchi Pharma Holdings, Inc. from 1997 to 2000.
He also worked as Vice President at Johnson & Johnson from 1980 to 1991 and as Vice President-Clinical Research at XOMA Corp.
from 1992 to 1995.
He was the Director, Chief Operating & Medical Officer at Cassava Sciences, Inc. from 1998 to 2022.
Dr. Friedmann also served as Medical Director at Abbott Laboratories.
He was an Advisor at Presidio Partners and President & Owner at Emet Research, Inc. Dr. Friedmann holds a doctorate degree from the University of California San Diego and Albert Einstein College of Medicine, Inc.

Antiguos cargos conocidos de Nadav Friedmann.

EmpresasCargoFin
FILANA THERAPEUTICS, INC. Director Técnico/Científico/I+D 20/12/2022
Emet Research, Inc.
Presidente 20/12/2022
DaIIchi Pharma Holdings, Inc.
Director Ejecutivo 01/04/2000
XOMA ROYALTY CORPORATION Director Técnico/Científico/I+D 01/01/1995
JOHNSON & JOHNSON Corporate Officer/Principal 01/01/1991
Ver el detalle de la experiencia de Nadav Friedmann.

Formación de Nadav Friedmann.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

71

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Emet Research, Inc.

DaIIchi Pharma Holdings, Inc.

Consumer Services